March 2-4, 2020
London

 

Content Library

Past Presentations, Reports and Interviews by Leading Industry Experts.

 

 

ADC London Post Event Report

 

 

Meet the Speakers at World ADC London 2019

 

 

 

Antibody Drug Conjugates Clinical E-Book

 

 

Getting Small to Enhance Targeting: Non-Internalizing Small Molecule-Drug Conjugates for the Treatment of Solid Tumours 

 

Samuele Cazzamalli

 

Screening for ADC Biotransformations Using Mass Spectrometry 

Connor Barry

 

 

Bispecific ADCs Bridging HER2 and Proclactin Receptor

 

Julian Andreev

 

  

MAM Workflow Customer Facing Presentation

 

Download Here 

 

  

World ADC San Diego Post Event Report 2017

 

Download Here 

 

Clinical Development of ADC-IO Combinations: Today and Tomorrow

Jay Harper, Ph.D., MedImmune Oncology Research

Download Here 

 

Antibody Drug Conjugates: Process Development and Analytical Considerations

Michael Hay – Bristol-Myers Squibb

Download Here 

 

Immunogenicity Assay Strategies for Antibody-Drug Conjugates

Seema Kumar, PhD, EMD Serono Research & Development Institute

Download Here 

 

 

Clinical Development of ADCs: ARX788, a Her2-targeting ADC as an Example – Ambrx

Yong-jiang Hei, M.D., Ph.D. Download Here 

 

 

Linker Design: Why so complex? – GNF

Bernhard Geierstanger Download Here 

 

 

New cryptophycins as promising payloads for ADC – Sanofi

Hervé Bouchard

Download Here 

 

Pall Life Sciences White Paper

 

New Genderless Sterile Connection Technology – A Quality By Design (QbD) Approach For Greater Sterility Assurance From Manufacturing To Use

Download Here 

 

Regulatory perspective for successful antibody-drug conjugate development

 

Wen Jin Wu

Download Here 

 

CD19 ADCs Effectively Targeting B Cell Malignancies – a clinical perspective.

 

Martin J.S. Dyer

Download Here 

 

CD19 ADCs Effectively Targeting B Cell Malignancies – a clinical perspective.

 

Nathan Tumey

Download Here